You haven't searched anything yet.
Full Time
Pharmaceutical
$111k-132k (estimate)
07/05/2024
08/31/2024
alnylam.com
CAMBRIDGE, MA
1,000 - 3,000
2002
Public
MARK JOHNSON
$200M - $500M
Pharmaceutical
Alnylam is a biopharmaceutical company that develops RNA interference therapeutics for genetically defined diseases.